Viatris Inc (VTRS) stock news · rev $14.30B
Viatris Inc (VTRS) is a drug manufacturers - specialty & generic company listed on US.
This VTRS news page leads with what Viatris Inc filed — not a scraped headline mill.
No cached 8-K sentence for VTRS yet. We will not pad this page with generic market recap.
Latest reported VTRS revenue for 2025-12-31 was $14.30B. Net income was -$3.51B. Revenue was down 3.0% from 2024-12-31 to 2025-12-31. VTRS currently screens at market cap $10.83B.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the VTRS stock page; for the tape open the quote page.
VTRS stock news FAQ
What are VTRS's latest revenue and net income?
Latest cached Viatris Inc (VTRS) revenue for Dec 31, 2025 was $14.30B. Net income was -$3.51B. Statements: https://lician.com/financials/vtrs
How did VTRS revenue change from the prior cached period?
Cached Viatris Inc (VTRS) revenue was down 3.0% from $14.74B (Dec 31, 2024) to $14.30B (Dec 31, 2025). Statements: https://lician.com/financials/vtrs
What is VTRS's market cap?
Viatris Inc (VTRS) market cap is $10.83B on the latest cached fundamentals snapshot.
What kind of company is VTRS?
Viatris Inc (VTRS) is a drug manufacturers - specialty & generic company listed on US.
Where is VTRS stock news listed?
Cached stock news for Viatris Inc (VTRS) is listed at https://lician.com/news/vtrs. Filings: https://lician.com/sec/vtrs
Not investment advice.